Announced Fri, 29 May · 12:23 IST

1. Approved the Audited Financial Results of the Company for the quarter and financial year ended on March 31, 2026 along with the Statement of Assets and Liabilities as on March 31, 2026 ....

Pat Growth 25pctDebt Equity ThresholdEbitda Margin ExpansionResults View source PDF

RELCHEMQ · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.6%1-day move
₹123.00
prior close
₹124.94
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0-0.8-2.1-2.1-1.6-1.5-2.4+0.2+0.8+0.7+10.6+10.6
Up moveDown movePending
AI summary

Reliance Chemotex Industries reported audited FY2026 results with net profit of Rs 526.15 Lacs, up ~30% from Rs 404.52 Lacs in FY2025, surpassing the 25% growth threshold. Revenue from operations was nearly flat at Rs 36,200.58 Lacs vs Rs 35,859.78 Lacs. Other income dropped sharply to Rs 382.94 Lacs from Rs 1,016.93 Lacs. Finance costs rose to Rs 2,490.48 Lacs and power & fuel costs increased 19.7% to Rs 4,607.51 Lacs, indicating cost pressures. The statutory auditor P K MB & Co issued an unmodified (clean) opinion. The Board recommended a final dividend of Rs 0.50 per share (5%). The company opted for lower tax regime under Section 115BAA from FY2027, recognising deferred tax reversal of Rs 77.23 Lacs. Government subsidy of Rs 2,764.03 Lacs is being amortised over asset life.

Likely market impact

Net profit growth of ~30% is positive but comes amid flat revenue and rising finance/power costs. A clean audit opinion is reassuring. High leverage (D/E ~1.87) and elevated interest burden warrant monitoring. Dividend payment provides modest shareholder return.